5upj: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "5upj" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:5upj.png|left|200px]] | [[Image:5upj.png|left|200px]] | ||
{{STRUCTURE_5upj| PDB=5upj | SCENE= }} | {{STRUCTURE_5upj| PDB=5upj | SCENE= }} | ||
===HIV-2 PROTEASE/U99283 COMPLEX=== | ===HIV-2 PROTEASE/U99283 COMPLEX=== | ||
{{ABSTRACT_PUBMED_7783120}} | {{ABSTRACT_PUBMED_7783120}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Virus protease]] | *[[Virus protease|Virus protease]] | ||
==Reference== | ==Reference== | ||
Revision as of 01:02, 26 July 2012
HIV-2 PROTEASE/U99283 COMPLEX
Template:ABSTRACT PUBMED 7783120
About this Structure
5upj is a 2 chain structure of Virus protease with sequence from Human immunodeficiency virus 2. Full crystallographic information is available from OCA.
See Also
Reference
- Romines KR, Watenpaugh KD, Tomich PK, Howe WJ, Morris JK, Lovasz KD, Mulichak AM, Finzel BC, Lynn JC, Horng MM, et al.. Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors. J Med Chem. 1995 May 26;38(11):1884-91. PMID:7783120
- Skulnick HI, Johnson PD, Howe WJ, Tomich PK, Chong KT, Watenpaugh KD, Janakiraman MN, Dolak LA, McGrath JP, Lynn JC, et al.. Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitors. J Med Chem. 1995 Dec 22;38(26):4968-71. PMID:8544171